Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of the Sleep-Breathing Treatment Algorithm: AutoEPAP iVAPS

NCT02317042 is registered in ClinicalTrials.gov with ResMed as lead sponsor.

NCT NCT02317042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02317042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of the Sleep-Breathing Treatment Algorithm: AutoEPAP iVAPS
Lead sponsor
ResMed
Phase
Not applicable
Overall status
Terminated
Start date
May 29, 2015
Completion date
November 29, 2015
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd), neuromuscular disease, obesity hypoventilation syndrome, respiratory insufficiency, upper airway obstruction